Large Cap · Healthcare · Medical Distribution
Large Cap · Healthcare · Medical Distribution
Get the AI take on CAH
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$235
Current price
$235
Median target
$275
Highest
$292
Forward P/E
Middle ground · 8% above avg
18.73x
Price / sales
Strong · Priced modestly against the revenue it brings in
0.22x
Price / FCF
Strong · Priced well within what its cash flow supports
12.09x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
14.10x
ROIC
Strong · Comfortably clears the bar for efficient capital use
18.4%
ROE
No signal · Not enough data to judge
-
Debt / equity
No signal · Not enough data to judge
-
Current ratio
Weak · Not enough on hand to cover near-term bills
0.88x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $54.69B | 32.5 | +14.2% | 52 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |